Description Usage Arguments Value
Calculate minimum sample size needed of AEBSD for testing both treatment effect in biomarker positve and interaction effect, and its comparison with BSD
1 | posint(rtrue,raux,ppv,lam1e,lam0e,lam1c,lam0c,tau,raccrual,powerdesired,alpha,costs)
|
rtrue |
the prevalence rates of patients with positive true biomarker |
raux |
the prevalence rates of patients with positive auxiliary biomarker |
lam1e |
hazrd rate for biomarker-positive subpopulation in the experimental treatment group |
lam0e |
hazrd rate for biomarker-negative subpopulation in the experimental treatment group |
lam1c |
hazrd rate for biomarker-positive subpopulation in the control treatment group |
lam0c |
hazrd rate for biomarker-negative subpopulation in the control treatment group |
tau |
minimum follow-up time |
raccrual |
accrual rate |
powerdesired |
desired design power |
alpha |
type-I error (for each test) |
costs |
cost vector including costscr (scrrening cost), costtrt (average treatment cost), costfol (follow-up cost) and costtest (biomarker test cost) for each randomized patient |
(1) The probability of randomizing patients with positive and negative auxiliary variable; (2) Number of randomized patients for AEBSD (3) Screening number for AEBSD (4) Number of randomized patients for BSD (5) Patient ratio (6) Cost ratio (7) Screening ratio
Add the following code to your website.
For more information on customizing the embed code, read Embedding Snippets.